SNY: Sanofi
About
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
Current Value
$47.951 Year Return
Current Value
$47.951 Year Return
Key Details
Market Cap
$120.34B
P/E Ratio
26.33
1Y Stock Return
3.11%
1Y Revenue Growth
5.18%
Dividend Yield
2.97%
Price to Book
1.5
Strategies that include SNY
Stock's related to SNY
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KROS | <0.01% | $2.17B | +73.87% | 0.00% |
| TRMD | <0.01% | $2.31B | -24.74% | 25.24% |
| ENSG | 0.01% | $8.28B | +33.91% | 0.17% |
| NTRA | -0.01% | $21.40B | +200.46% | 0.00% |
| DAVE | -0.03% | $1.04B | +1,258.83% | 0.00% |
| QNST | 0.03% | $1.19B | +93.14% | 0.00% |
| GHM | 0.03% | $464.78M | +132.21% | 0.00% |
| TEO | -0.03% | $1.69B | +87.97% | 0.00% |
| MUSA | 0.05% | $10.62B | +42.37% | 0.34% |
| RUM | -0.05% | $1.61B | +13.37% | 0.00% |
| SPOT | 0.05% | $90.80B | +159.59% | 0.00% |
| LKQ | -0.06% | $9.77B | -17.44% | 3.20% |
| CEG | 0.06% | $73.37B | +91.48% | 0.59% |
| TRVG | -0.06% | $37.05M | -37.92% | 0.00% |
| DOCS | 0.09% | $9.62B | +114.35% | 0.00% |
| ABEO | 0.09% | $256.04M | +41.25% | 0.00% |
| DRS | 0.09% | $9.28B | +88.06% | 0.00% |
| BHP | 0.09% | $133.61B | -15.74% | 5.55% |
| FLEX | 0.09% | $14.48B | +96.03% | 0.00% |
| SYK | -0.10% | $148.17B | +32.36% | 0.82% |
ETF's related to SNY
News
Yahoo
Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. Despite significant volatility, global markets reported gains in the third quarter. The Ariel Global fund appreciated +6.94% in the quarter outperforming the +6.61% return of its primary benchmark, the MSCI ACWI […]
Yahoo
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,537,214,304 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi
SeekingAlpha
The BlackRock Sustainable U.S. Value Equity Fund posted returns of 4.64% (Institutional shares) for the third quarter of 2024. Click here to read the full commentary.
SeekingAlpha
BlackRock Equity Dividend Fund posted returns of 6.39% (Institutional shares) and 6.31% (Investor A shares, without sales charge) for the third quarter of 2024.
SeekingAlpha
3Q24(notannualized)YTD(notannualized)1 Year3 Year5 Years10 YearsInstitutional5.614.5312.15-1.710.031.29Investor A (Without Sales...
SeekingAlpha
BlackRock High Equity Income Fund posted returns of 6.71% (Institutional shares) and 6.63% (Investor A shares, without sales charge) for the third quarter of 2024.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.